Delivery Order SPE2DB22D3301-SPE2DB24FX5KB
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,059.30, is a delivery order for the supply of 4562353061 - CITALOPRAM HBR 10 MG TABLET 100S. The contract has an ultimate completion date of October 2, 2023 and uses a firm fixed-price pricing type. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
- This federal contract award, valued at $1,542.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4564653992 CITALOPRAM HBR 20 MG TABLET 500S, with a completion date of May 21, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $76,317.93 Firm Fixed Price Delivery Order contract is for the supply of 4567039802 CITALOPRAM HBR 20 MG TABLET 500S and has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $6,062.81 with a completion date of April 26, 2023. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,560,712,462 units of Citalopram HBR 20 mg tablets. The contract is a firm fixed-price award and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,409.47, is for the delivery of Citalopram HBR 20 mg tablets in quantities of 500 per bottle. It is a firm fixed-price delivery order contract with an ultimate completion date of October 17, 2023. The contract award is not designated as a set-aside and appears to be part of a larger Indefinite...
- This federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor, is for the delivery of Citalopram HBR 20 mg tablets in 500-count bottles. The contract has a ceiling value of $18,288.72 and a period of performance through November 2024. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- This federal contract award, valued at $5,175.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of 4,565,911 units of Citalopram HBR 20 mg tablets. The contract has a firm fixed price and an ultimate completion date of September 24, 2024. This award is a delivery order issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB24FS88N, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,890.15 firm fixed-price delivery order is for the supply of 4563867331 - CITALOPRAM HBR 20 MG TABLET 500S. The contract has an ultimate completion date of March 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,914.85 firm fixed-price delivery order is for the supply of 4,566,554,867 units of Citalopram HBr 20 mg tablets to support military healthcare programs. The contract has an ultimate completion date of November 27, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,680,284 units of Citalopram HBR 40 mg tablets. The $3,805.46 firm fixed-price Delivery Order has a completion date of February 16, 2024 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that provides a comprehensive range of pharmaceutical products and medical supplies to...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FX5KBDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,342.10, is for the delivery of 4562817233 CITALOPRAM HBR 20 MG TABLET 500S. It is a Firm Fixed Price Delivery Order contract with a completion date of November 15, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 11/14/23 |